一般演題（ISポスター）1 ISポスター発表1：International　session 1

[ISP-006] Tisotumab Vedotin in Japanese Patients with Recurrent or Metastatic Cervical Cancer：Results from the Phase 1/2 InnovaTV 206 Study

オンデマンド配信

Kan Yonemori¹, ^○Kenichi Harano², Kosei Hasegawa³, Takashi Iwata⁴, Hidenori Kato⁵, Kazuhiro Takehara⁶, Yasuyuki Hirashima⁷, Hisamori Kato⁸, Chaitali Passey⁹, Jeppe Klint Buchbjerg¹⁰, Camilla Mondrup Andreassen¹⁰, Leonardo Nicacio¹¹, Ibrahima Soumaoro⁹, Keiichi Fujiwara³ (1.National Cancer Center Hospital, Tokyo, Japan, 2.National Cancer Center Hospital East, Chiba, Japan, 3.Saitama Medical University International Medical Center, Saitama, Japan, 4.Keio University School of Medicine, Tokyo, Japan, 5.National Hospital Organization, Hokkaido Cancer Center, Sapporo, Japan, 6.NHO Shikoku Cancer Center, Matsuyama, Japan, 7.Shizuoka Cancer Center, Shizuoka, Japan, 8.Kanagawa Cancer Center, Kanagawa, Japan, 9.Genmab US, Inc., Princeton, NJ, USA, 10.Genmab, Copenhagen, Denmark, 11.Seagen Inc., Bothell, WA, USA)